A Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Compare the Efficacy and Safety of Denosumab Versus Placebo in Males With Low Bone Mineral Density.
Latest Information Update: 16 Oct 2021
At a glance
- Drugs Denosumab (Primary)
- Indications Bone resorption; Male osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms ADAMO
- Sponsors Amgen
- 06 Oct 2013 Results of the transiliac crest bone biopsy substudy (n=29) presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
- 14 Nov 2012 One-year outcomes presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 16 Oct 2012 Results presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.